Clinical Trial

tDCS for Cancer-Related Fatigue and Weakness

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task endurance, maximal voluntary contraction force, and neuromuscular markers. Neural mechanisms will be assessed via EEG, TMS, and MRI.
Trial Details
NCT Number NCT07159100
Lead Sponsor Kessler Foundation
Conditions Cancer-related Fatigue, Neuromodulation
Enrollment 75 participants
Start Date 2025-09-10
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08